Patients with Asthma and Comorbid Allergic Rhinitis: Is Optimal Quality of Life Achievable in Real Life?

被引:21
作者
Braido, Fulvio [1 ]
Baiardini, Ilaria [1 ]
Menoni, Stefania [2 ]
Gani, Federica [3 ]
Senna, Gian Enrico [4 ]
Ridolo, Erminia [5 ]
Schoepf, Veruska [1 ]
Rogkakou, Anthi [1 ]
Canonica, Giorgio Walter [1 ]
机构
[1] Osped S Martino Genoa, Allergy & Resp Dis Clin, Genoa, Italy
[2] Univ Genoa, Dept Hlth Sci, Biostat Unit, Genoa, Italy
[3] AOU San Luigi, Resp Dis Div, Allergy Unit, Turin, Italy
[4] Verona Major Hosp, Allergy Serv, Verona, Italy
[5] Univ Parma, I-43100 Parma, Italy
来源
PLOS ONE | 2012年 / 7卷 / 02期
关键词
D O I
10.1371/journal.pone.0031178
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives: Asthma trials suggest that patients reaching total disease control have an optimal Health Related Quality of Life (HRQoL). Moreover, rhinitis is present in almost 80% of asthmatics and impacts asthma control and patient HRQoL. We explored whether optimal HRQoL was reachable in a real-life setting, and evaluated the disease and patient related patterns associated to optimal HRQoL achievement. Methods and Findings: Asthma and rhinitis HRQoL, illness perception, mood profiles, rhinitis symptoms and asthma control were assessed by means of validated tools in patients classified according to GINA and ARIA guidelines. Optimal HRQoL, identified by a Rhinasthma Global Summary (GS) score <= 20 (score ranging from 0 to 100, where 100 represents the worst possible HRQoL), was reached by 78/209 (37.32%). With the exception of age, no associations were found between clinical and demographic characteristics and optimal HRQoL achievement. Patients reaching an optimal HRQoL differed in disease perception and mood compared to those not reaching an optimal HRQoL. Asthma control was significantly associated with optimal HRQoL (chi(2) = 49.599; p < 0.001) and well-controlled and totally controlled patients significantly differed in achieving optimal HRQoL (chi(2) = 7.617; p < 0.006). Conclusion: Approximately one third of the patients in our survey were found to have an optimal HRQoL. While unsatisfactory disease control was the primary reason why the remainder failed to attain optimal HRQoL, it is clear that illness perception and mood also played parts. Therefore, therapeutic plans should be directed not only toward achieving the best possible clinical control of asthma and comorbid rhinitis, but also to incorporating individualized elements according to patient-related characteristics.
引用
收藏
页数:6
相关论文
共 23 条
  • [1] [Anonymous], 1995, Global Strategy for Asthma Management and Prevention
  • [2] [Anonymous], 1992, POMS MANUAL PROFILE
  • [3] Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma
    Baiardini, I
    Pasquali, M
    Giardini, A
    Specchia, C
    Passalacqua, G
    Venturi, S
    Braido, F
    Bonini, S
    Majani, G
    Canonica, GW
    [J]. ALLERGY, 2003, 58 (04) : 289 - 294
  • [4] The correlation between asthma control and health status: the GOAL study
    Bateman, E. D.
    Bousquet, J.
    Keech, M. L.
    Busse, W. W.
    Clark, T. J. H.
    Pedersen, S. E.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2007, 29 (01) : 56 - 63
  • [5] Achieving guideline-based asthma control: does the patient benefit?
    Bateman, ED
    Frith, LF
    Braunstein, GL
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (03) : 588 - 595
  • [6] Can guideline-defined asthma control be achieved? The gaining optimal asthma control study
    Bateman, ED
    Boushey, HA
    Bousquet, J
    Busse, WW
    Clark, TJH
    Pauwels, RA
    Pedersen, SE
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (08) : 836 - 844
  • [7] Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen)
    Bousquet, J.
    Khaltaev, N.
    Cruz, A. A.
    Denburg, J.
    Fokkens, W. J.
    Togias, A.
    Zuberbier, T.
    Baena-Cagnani, C. E.
    Canonica, G. W.
    van Weel, C.
    Agache, I.
    Ait-Khaled, N.
    Bachert, C.
    Blaiss, M. S.
    Bonini, S.
    Boulet, L. -P.
    Bousquet, P. -J.
    Camargos, P.
    Carlsen, K. -H.
    Chen, Y.
    Custovic, A.
    Dahl, R.
    Demoly, P.
    Douagui, H.
    Durham, S. R.
    van Wijk, R. Gerth
    Kalayci, O.
    Kaliner, M. A.
    Kim, Y. -Y.
    Kowalski, M. L.
    Kuna, P.
    Le, L. T. T.
    Lemiere, C.
    Li, J.
    Lockey, R. F.
    Mavale-Manuel, S.
    Meltzer, E. O.
    Mohammad, Y.
    Mullol, J.
    Naclerio, R.
    Hehir, R. E. O.
    Ohta, K.
    Ouedraogo, S.
    Palkonen, S.
    Papadopoulos, N.
    Passalacqua, G.
    Pawankar, R.
    Popov, T. A.
    Rabe, K. F.
    Rosado-Pinto, J.
    [J]. ALLERGY, 2008, 63 : 8 - +
  • [8] Severity and impairment of allergic rhinitis in patients consulting in primary care
    Bousquet, J
    Neukirch, F
    Bousquet, PJ
    Gehano, P
    Klossek, JM
    Le Gal, M
    Allaf, B
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (01) : 158 - 162
  • [9] Allergic rhinitis and asthma ad hoc survey: clinical and psychological perspectives
    Braido, F.
    Baiardini, I.
    Brandi, S.
    Porcu, A.
    Canonica, G. W.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2007, 37 (05) : 788 - 793
  • [10] Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA2LEN taskforce position paper
    Braido, F.
    Bousquet, P. J.
    Brzoza, Z.
    Canonica, G. W.
    Compalati, E.
    Fiocchi, A.
    Fokkens, W.
    Gerth van Wijk, R.
    La Grutta, S.
    Lombardi, C.
    Maurer, M.
    Pinto, A. M.
    Ridolo, E.
    Senna, G. E.
    Terreehorst, I.
    Todo Bom, A.
    Bousquet, J.
    Zuberbier, T.
    Baiardini, I.
    [J]. ALLERGY, 2010, 65 (08) : 959 - 968